anmelden
SLI
2.307,17
PKT
-3,91
PKT
-0,17
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.03.05 | Novartis Neutral | Sarasin Research | |
| 22.03.05 | Swisscom Neutral | Helvea | |
| 21.03.05 | ABB (Asea Brown Boveri) Neutral | Sarasin Research | |
| 22.03.05 | Holcim Accumulate | Helvea | |
| 21.03.05 | Novartis Kaufen | Helaba Trust | |
| 22.03.05 | ABB (Asea Brown Boveri) Accumulate | Helvea | |
| 22.03.05 | Geberit Reduce | Helvea | |
| 22.03.05 | Novartis Accumulate | Helvea | |
| 21.03.05 | Geberit Market Outperform | Vontobel | |
| 21.03.05 | Novartis Neutral | Sarasin Research | |
| 17.03.05 | UBS Buy | Helvea | |
| 18.03.05 | ABB (Asea Brown Boveri) Overweight | Lehman Brothers | |
| 18.03.05 | Geberit Reduce | Helvea | |
| 16.03.05 | Lindt Sector Outperform | Vontobel | |
| 17.03.05 | Roche Buy | Helvea | |
| 16.03.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
| 17.03.05 | Novartis Outperform | Goldman Sachs | |
| 17.03.05 | Lindt In-Line | Goldman Sachs | |
| 17.03.05 | Roche In-Line | Goldman Sachs | |
| 16.03.05 | Swiss Life Sell | Merck Finck & Co | |
| 16.03.05 | Kühne + Nagel International Neutral | Sarasin Research | |
| 15.03.05 | UBS Overweight | JP Morgan | |
| 15.03.05 | Lindt Neutral | Sarasin Research | |
| 15.03.05 | Kühne + Nagel International Market Perform | Vontobel | |
| 15.03.05 | UBS Overweight | JP Morgan | |
| 16.03.05 | Lindt Accumulate | Helvea | |
| 15.03.05 | Logitech Neutral | Sarasin Research | |
| 14.03.05 | Swiss Life Marketperformer | LB Rheinland-Pfalz | |
| 14.03.05 | Kühne + Nagel International Neutral | Sarasin Research | |
| 14.03.05 | Swiss Life Buy | M.M. Warburg | |
| 16.03.05 | Kühne + Nagel International Neutral | Helvea | |
| 14.03.05 | Swiss Life Outperform | HypoVereinsbank | |
| 15.03.05 | Swiss Life Akkumulieren | Nord LB | |
| 11.03.05 | Swisscom Neutral | Sarasin Research | |
| 17.03.05 | UBS Outperform | Credit Suisse First Boston | |
| 11.03.05 | Lindt Neutral | Sarasin Research | |
| 14.03.05 | Swisscom Underweight | Lehman Brothers | |
| 11.03.05 | Novartis Neutral | Sarasin Research | |
| 11.03.05 | Novartis Buy | Helvea | |
| 10.03.05 | Kühne + Nagel International Neutral | Sarasin Research |